1. Arrighi HM, Metter EJ, Guess HA et al. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology 1991; 38 (1 Suppl): 4–8.
2. Madersbacher S, Alivizatos G, Nordling J et al. EAU 2004 guidelines on assessment, therapy and follow--up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004; 46(5): 547–554.
3. Rassweiler J, Teber D, Kuntz R et al. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol 2006; 50(5): 969–979.
4. Oelke M, Bachmann A, Descazeaud A et al. EAU 2012 Guidelines on the Management of Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO).
5. Ho HSS, Yip SKH, Lim KB et al. A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 2007; 52(2): 517–522.
6. Gratzke C, Schlenker B, Seitz M et al. Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol 2007; 177(4): 1419–1422.
7. Varkarakis I, Kyriakakis Z, Delis A et al. Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology 2004; 64(2): 306–310.
8. Tubaro A, Carter S, Hind A et al. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol 2001; 166(1): 172–176.
9. Costello AJ, Johnson DE, Bolton DM. Nd:YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy. Lasers Surg Med 1992; 12(2): 121–124.
10. Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006; 49(6): 961–969.
11. Hoffman RM, MacDonald R, Slaton JW et al. Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol 2003; 169(1): 210–215.
12. Wilson LC, Gilling PJ. From coagulation to enucleation: the use of lasers in surgery for benign prostatic hyperplasia. Nat Clin Pract Urol 2005; 2(9): 443–448.
13. McAllister WJ, Gilling PJ. Vaporization of the prostate. Curr Opin Urol 2004; 14(1): 31–34.
14. Te AE. The development of laser prostatectomy. BJU Int 2004; 93(3): 262–265.
15. Ruszat R, Seitz M, Wyler SF et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008; 54(4): 893–901.
16. Bachmann A, Muir GH, Collins EJ et al. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 2012; 61(3): 600–607.
17. 29th World Congress of Endourology & SWL WCE 2011 Scientific Program & Abstracts. J Endourol 2011; 25 (Suppl 1): P1–A373.
18. Rieken M, Bonkat G, Mueller G et al. 2174 the influence of increased maximum power output on the outcome of photoselective vaporization of the prostate with the greenlight laser – three-year results of a comparison between the 80-w KTP and the 120-w HPS-laser. The J Urol 2012; 187: e877.
19. Rieken M, Wyler S, Rentsch C et al. Long-term results of transurethral KTP-laser vaporization of the prostate. The Journal of Urology 2009; 181: 767.
20. Rieken M, Bonkat G, Rentsch C et al. MP-06.04: Long-Term Results of Laser Vaporization of the Prostate with the 80-W KTP-Laser. Urology 2009; 74: S69.
21. Rieken M, Bonkat G, Wyler S e tal. UP-3.061: Incidence of Adenocarcinoma of the Prostate and Feasibility of Laparoscopic Radical Prostatectomy after Photoselective Vaporization of the Prostate for Prostate Enlargement. Urology 2009; 74: S312–S313.
22. Rieken M, Bonkat G, Rentsch C et al. 891 long--term results of photoselective vaporization of the prostate in patients with ongoing anticoagulation, thrombocyte aggregation inhibition and large prostates. Eur Urol Supplements 2010; 9: 281.
23. Rieken M, Bonkat G, Lehmann K et al. 2268 photoselective vaporization of the prostate with the 80-w KTP-laser versus transurethral resection of the prostate & endash; long-term results of a prospective bicenter trial. J Urol 2011; 185: e909.
24. Ruszat R, Seitz M, Wyler SF et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 2009; 104(6): 820–825.
25. Rieken M, Mueller G, Bonkat G et al. 2173 photoselective vaporization of the prostate with the 120-w HPS greenlight laser versus laser vaporization of the prostate with the 980 nm 200-w high intensity diode laser – 3-year results of a prospective non-randomized trial. J Urol 2012; 187: e876.
26. Bouchier-Hayes DM, Anderson P, Van Appledorn S et al. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006; 20(8): 580–585.
27. Rajbabu K, Chandrasekara SK, Barber NJ et al. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 2007; 100(3): 593–598.
28. Alivizatos G, Skolarikos A, Chalikopoulos D et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas > 80 ml: 12-mo results of a randomized prospective study. Eur Urol 2008; 54(2): 427–437.
29. Te AE, Malloy TR, Stein BS et al. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006; 97(6): 1229–1233.
30. Hai MA. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology 2009; 73(4): 807–810.
31. Bouchier-Hayes DM, Van Appledorn S, Bugeja P et al. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl--phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 2010; 105(7): 964–969.
32. Horasanli K, Silay MS, Altay B et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 2008; 71(2): 247–251.
33. Al-Ansari A, Younes N, Sampige VP et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 2010; 58(3): 349–355.
34. Lukacs B, Loeffler J, Bruyère F et al. Photoselective Vaporization of the Prostate with GreenLight 120-W Laser Compared with Monopolar Transurethral Resection of the Prostate: A Multicenter Randomized Controlled Trial. Eur Urol 2012; 61(6): 1165–1173.
35. Capitán C, Blázquez C, Martin MD et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011; 60(4): 734–739.
36. Pereira-Correia JA, de Moraes Sousa KD, Santos JB et al. GreenLight HPSTM 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 2012; 110(8): 1184–1189.
37. Bachmann A, Woo HH, Wyler S. Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: a critical review of evidence. Curr Opin Urol 2012; 22(1): 22–33.
38. Thangasamy IA, Chalasani V, Bachmann A et al. Photoselective Vaporisation of the Prostate Using 80-W and 120-W Laser Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Systematic Review with Meta-Analysis from 2002 to 2012. Eur Urol 2012; 62(2): 315–323.